{"name":"Medinova AG","slug":"medinova-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Canesten vaginal tablets","genericName":"Canesten vaginal tablets","slug":"canesten-vaginal-tablets","indication":"Other","status":"marketed"},{"name":"Fluomizin vaginal tablets","genericName":"Fluomizin vaginal tablets","slug":"fluomizin-vaginal-tablets","indication":"Other","status":"marketed"},{"name":"Placebo cream without active substance","genericName":"Placebo cream without active substance","slug":"placebo-cream-without-active-substance","indication":"Control comparator in phase 3 clinical trials (indication-dependent on active comparator)","status":"phase_3"}]}],"pipeline":[{"name":"Canesten vaginal tablets","genericName":"Canesten vaginal tablets","slug":"canesten-vaginal-tablets","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fluomizin vaginal tablets","genericName":"Fluomizin vaginal tablets","slug":"fluomizin-vaginal-tablets","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo cream without active substance","genericName":"Placebo cream without active substance","slug":"placebo-cream-without-active-substance","phase":"phase_3","mechanism":"A placebo cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","indications":["Control comparator in phase 3 clinical trials (indication-dependent on active comparator)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2019-01-28","type":"pipeline","source":"Cantech Letter","summary":"Acerus Pharmaceutical gets a target price reduction from Mackie Research - Cantech Letter","headline":"Acerus Pharmaceutical gets a target price reduction from Mackie Research","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}